This module uses fundamental data of CannBioRx Life to approximate its Piotroski F score. CannBioRx Life F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of CannBioRx Life Sciences. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about CannBioRx Life financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out CannBioRx Life Altman Z Score, CannBioRx Life Correlation, CannBioRx Life Valuation, as well as analyze CannBioRx Life Alpha and Beta and CannBioRx Life Hype Analysis.
CannBioRx
Piotroski F Score
Ptb Ratio
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Capex To Depreciation
Pb Ratio
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Average Inventory
Cash Per Share
Pocfratio
Interest Coverage
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Graham Number
Shareholders Equity Per Share
Debt To Equity
Graham Net Net
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Ebt Per Ebit
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Quick Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Days Of Inventory Outstanding
Cash Flow Coverage Ratios
Price To Book Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Return On Assets
Price Fair Value
Return On Equity
Sale Purchase Of Stock
Change In Cash
Change In Working Capital
Other Cashflows From Financing Activities
Capital Expenditures
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Free Cash Flow
Begin Period Cash Flow
Total Cashflows From Investing Activities
Other Non Cash Items
Total Cash From Operating Activities
Other Cashflows From Investing Activities
Depreciation
Stock Based Compensation
Issuance Of Capital Stock
Total Assets
Total Current Liabilities
Total Stockholder Equity
Retained Earnings
Cash And Short Term Investments
Capital Surpluse
Total Liab
Total Current Assets
Short Term Debt
Common Stock
Other Current Liab
Net Debt
Cash
Non Current Assets Total
Non Currrent Assets Other
Common Stock Shares Outstanding
Short Term Investments
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Short Long Term Debt Total
Accounts Payable
Net Receivables
Inventory
Other Current Assets
Net Invested Capital
Short Long Term Debt
Accumulated Other Comprehensive Income
Capital Stock
Net Working Capital
Intangible Assets
Long Term Debt
Interest Expense
Selling General Administrative
Operating Income
Income Before Tax
Net Income Applicable To Common Shares
Tax Provision
Interest Income
Other Operating Expenses
Ebit
Ebitda
Total Operating Expenses
Total Other Income Expense Net
Income Tax Expense
Depreciation And Amortization
Research Development
Net Interest Income
Selling And Marketing Expenses
Gross Profit
Net Income From Continuing Ops
Cost Of Revenue
Reconciled Depreciation
Probability Of Bankruptcy
At this time, CannBioRx Life's Short Term Debt is fairly stable compared to the past year. Short and Long Term Debt Total is likely to climb to about 1.9 M in 2025, whereas Long Term Debt is likely to drop slightly above 17 K in 2025. At this time, CannBioRx Life's Average Payables is fairly stable compared to the past year. Payables Turnover is likely to climb to 0.06 in 2025, despite the fact that Book Value Per Share is likely to grow to (0.37).
At this time, it appears that CannBioRx Life's Piotroski F Score is Unavailable. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
The critical factor to consider when applying the Piotroski F Score to CannBioRx Life is to make sure CannBioRx is not a subject of accounting manipulations and runs a healthy internal audit department. So, if CannBioRx Life's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if CannBioRx Life's financial numbers are properly reported.
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between CannBioRx Life's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards CannBioRx Life in a much-optimized way.
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Book Value Per Share
(0.37)
At this time, CannBioRx Life's Book Value Per Share is fairly stable compared to the past year.
About CannBioRx Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CannBioRx Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CannBioRx Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CannBioRx Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.